Sign in to view content

Treatment Effect of Intravitreal Aflibercept Injection by Baseline Factors in Moderately Severe-to-Severe NPDR in PANORAMA

Nathan C. Steinle, MD

Video
Published 2020

Related

Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy
Andrew N. Antoszyk, MD FASRS
Updates from the Field
2016
Impact of Race on Vision Outcomes in RanibizumabTreated Patients With Diabetic Macular Edema: A Meta-Analysis of 5 Clinical Trial
M. Ali Khan, MD, FACS, FASRS
Updates from the Field
2021
Benefits and Value of Treatment for Diabetic Macular Edema
Paul Hahn, MD, PhD, FASRS
Updates from the Field
2022

Category: Diabetic Retinopathy

See more